SEC Form 4 · accession 0000899243-18-024043
Eledon Pharmaceuticals, Inc. · ELDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine C. Turkel
Officer — President
Period of report
Sep 5, 2018
Accepted (ET)
Sep 7, 2018 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2018 | P | 805 | $3.966 | A | 805 | I | By Spouse's IRA |
| Common Stock | holding | — | — | — | 44,519 | D |
Table II — derivative securities
No Table II lines on this filing.